GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (MEX:RMD) » Definitions » Cyclically Adjusted Book per Share

ResMed (MEX:RMD) Cyclically Adjusted Book per Share : MXN485.20 (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is ResMed Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

ResMed's adjusted book value per share for the three months ended in Mar. 2025 was MXN773.869. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN485.20 for the trailing ten years ended in Mar. 2025.

During the past 12 months, ResMed's average Cyclically Adjusted Book Growth Rate was 12.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 10.60% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 8.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of ResMed was 32.00% per year. The lowest was 6.90% per year. And the median was 14.75% per year.

As of today (2025-05-25), ResMed's current stock price is MXN4745.00. ResMed's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was MXN485.20. ResMed's Cyclically Adjusted PB Ratio of today is 9.78.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of ResMed was 19.96. The lowest was 5.35. And the median was 9.90.


ResMed Cyclically Adjusted Book per Share Historical Data

The historical data trend for ResMed's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Cyclically Adjusted Book per Share Chart

ResMed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 253.21 278.52 337.15 341.34 421.13

ResMed Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 336.73 421.13 333.76 466.93 485.20

Competitive Comparison of ResMed's Cyclically Adjusted Book per Share

For the Medical Instruments & Supplies subindustry, ResMed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ResMed's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where ResMed's Cyclically Adjusted PB Ratio falls into.


;
;

ResMed Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ResMed's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=773.869/134.9266*134.9266
=773.869

Current CPI (Mar. 2025) = 134.9266.

ResMed Quarterly Data

Book Value per Share CPI Adj_Book
201506 177.293 100.684 237.591
201509 176.901 100.392 237.756
201512 187.221 99.792 253.136
201603 205.218 100.470 275.597
201606 222.829 101.688 295.664
201609 243.268 101.861 322.236
201612 248.979 101.863 329.796
201703 246.339 102.862 323.128
201706 249.226 103.349 325.375
201709 261.449 104.136 338.755
201712 277.570 104.011 360.073
201803 263.108 105.290 337.168
201806 283.557 106.317 359.862
201809 249.444 106.507 316.005
201812 268.057 105.998 341.214
201903 273.532 107.251 344.117
201906 277.084 108.070 345.944
201909 290.736 108.329 362.118
201912 294.524 108.420 366.529
202003 365.741 108.902 453.145
202006 397.804 108.767 493.479
202009 408.388 109.815 501.775
202012 391.675 109.897 480.882
202103 380.570 111.754 459.481
202106 394.391 114.631 464.217
202109 427.021 115.734 497.834
202112 441.370 117.630 506.272
202203 446.339 121.301 496.476
202206 461.793 125.017 498.398
202209 471.480 125.227 508.001
202212 496.106 125.222 534.555
202303 482.450 127.348 511.162
202306 481.441 128.729 504.621
202309 503.361 129.860 523.002
202312 517.215 129.419 539.224
202403 523.119 131.776 535.625
202406 606.597 132.554 617.455
202409 696.923 133.029 706.865
202412 746.004 133.157 755.918
202503 773.869 134.927 773.869

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


ResMed  (MEX:RMD) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

ResMed's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4745.00/485.20
=9.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of ResMed was 19.96. The lowest was 5.35. And the median was 9.90.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


ResMed Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of ResMed's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


ResMed Business Description

Industry
Address
9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.